Search research articles
Contact Us
Filters
Showing results (21-30 of 186) with videos related to
Page
of 19
Sort By:
Experimental & Molecular Medicine
|
January 31, 2023
TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia
Chenfei Wang, Jia Lu, Xudong Sha, et al.
Phytotherapy Research : PTR
|
April 1, 2024
Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy
Jiani Lu, Danmei Yu, Hongtao Li, et al.
Neurobiology of Disease
|
August 31, 2019
KCa3.1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway
Tianjiao Wei, Yanxia Wang, Weirong Xu, et al.
Bioconjugate Chemistry
|
October 17, 2008
Quantum dots bearing lectin-functionalized nanoparticles as a platform for in vivo brain imaging
Xiaoling Gao, Jun Chen, Jiyao Chen, et al.
Frontiers in Immunology
|
May 16, 2022
Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response
Yan Chen, Zepang Sun, Li Wan, et al.
Journal of Advanced Research
|
November 6, 2024
Trichosanthin elicits antitumor activity via MICU3 mediated mitochondria calcium influx
Yunbin Zhang, Xuping Ding, Qian Zhang, et al.
Molecular and Cellular Neurosciences
|
August 29, 2016
KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease
Mengni Yi, Panpan Yu, Qin Lu, et al.
ACS Pharmacology & Translational Science
|
July 17, 2025
Critical Residues in the Gβ Subunit Mediate Selective Recruitment of the Gαq Heterotrimer to Activated G Protein-Coupled Receptors
Yunjin Yao, Dongxue Wang, Shiqi Wang, et al.
Biomedical Chromatography : BMC
|
March 16, 2017
A novel assay to determine acetylcholinesterase activity: The application potential for screening of drugs against Alzheimer's disease
Liang Peng, Zhengxing Rong, Hao Wang, et al.
Frontiers in Pharmacology
|
January 21, 2017
The Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer's Disease
Tianjiao Wei, Mengni Yi, Wen Gu, et al.
Page
of 19
Search research articles
Search
Showing results (21-30 of 186) with videos related to
Sort By:
Page
of 19
Experimental & Molecular Medicine
|
January 31, 2023
TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia
Chenfei Wang, Jia Lu, Xudong Sha, et al.
Phytotherapy Research : PTR
|
April 1, 2024
Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy
Jiani Lu, Danmei Yu, Hongtao Li, et al.
Neurobiology of Disease
|
August 31, 2019
KCa3.1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway
Tianjiao Wei, Yanxia Wang, Weirong Xu, et al.
Bioconjugate Chemistry
|
October 17, 2008
Quantum dots bearing lectin-functionalized nanoparticles as a platform for in vivo brain imaging
Xiaoling Gao, Jun Chen, Jiyao Chen, et al.
Frontiers in Immunology
|
May 16, 2022
Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response
Yan Chen, Zepang Sun, Li Wan, et al.
Journal of Advanced Research
|
November 6, 2024
Trichosanthin elicits antitumor activity via MICU3 mediated mitochondria calcium influx
Yunbin Zhang, Xuping Ding, Qian Zhang, et al.
Molecular and Cellular Neurosciences
|
August 29, 2016
KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease
Mengni Yi, Panpan Yu, Qin Lu, et al.
ACS Pharmacology & Translational Science
|
July 17, 2025
Critical Residues in the Gβ Subunit Mediate Selective Recruitment of the Gαq Heterotrimer to Activated G Protein-Coupled Receptors
Yunjin Yao, Dongxue Wang, Shiqi Wang, et al.
Biomedical Chromatography : BMC
|
March 16, 2017
A novel assay to determine acetylcholinesterase activity: The application potential for screening of drugs against Alzheimer's disease
Liang Peng, Zhengxing Rong, Hao Wang, et al.
Frontiers in Pharmacology
|
January 21, 2017
The Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer's Disease
Tianjiao Wei, Mengni Yi, Wen Gu, et al.
Page
of 19